Boston Partners bought a new position in Varex Imaging Co. (NASDAQ:VREX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 597,762 shares of the company's stock, valued at approximately $8,718,000. Boston Partners owned 1.45% of Varex Imaging as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in VREX. Isthmus Partners LLC raised its holdings in shares of Varex Imaging by 0.8% during the fourth quarter. Isthmus Partners LLC now owns 149,874 shares of the company's stock valued at $2,187,000 after acquiring an additional 1,260 shares in the last quarter. Intech Investment Management LLC raised its holdings in Varex Imaging by 13.7% in the 3rd quarter. Intech Investment Management LLC now owns 16,267 shares of the company's stock worth $194,000 after purchasing an additional 1,959 shares in the last quarter. Inspire Advisors LLC lifted its position in shares of Varex Imaging by 22.5% in the 4th quarter. Inspire Advisors LLC now owns 17,334 shares of the company's stock worth $253,000 after purchasing an additional 3,185 shares during the period. Quest Partners LLC bought a new stake in shares of Varex Imaging during the 3rd quarter valued at about $41,000. Finally, New York State Common Retirement Fund increased its position in shares of Varex Imaging by 60.7% during the fourth quarter. New York State Common Retirement Fund now owns 9,531 shares of the company's stock valued at $139,000 after buying an additional 3,600 shares during the period.
Wall Street Analysts Forecast Growth
VREX has been the topic of several research reports. StockNews.com raised Varex Imaging from a "hold" rating to a "buy" rating in a research report on Friday, February 7th. B. Riley reaffirmed a "buy" rating and issued a $22.00 price target (up from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th. Finally, Oppenheimer lowered their price objective on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research report on Friday, February 7th.
Check Out Our Latest Report on VREX
Insider Transactions at Varex Imaging
In related news, SVP Kimberley E. Honeysett sold 4,007 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total transaction of $51,329.67. Following the completion of the sale, the senior vice president now owns 4,002 shares of the company's stock, valued at $51,265.62. This trade represents a 50.03 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 4.30% of the stock is owned by insiders.
Varex Imaging Stock Down 1.1 %
Shares of NASDAQ VREX traded down $0.14 on Tuesday, reaching $12.31. 374,231 shares of the company's stock traded hands, compared to its average volume of 527,389. The business's 50 day simple moving average is $13.26 and its two-hundred day simple moving average is $13.44. Varex Imaging Co. has a 12 month low of $10.19 and a 12 month high of $18.30. The company has a market cap of $507.17 million, a price-to-earnings ratio of -10.52 and a beta of 0.56. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02.
Varex Imaging (NASDAQ:VREX - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. As a group, equities research analysts forecast that Varex Imaging Co. will post 0.53 EPS for the current fiscal year.
Varex Imaging Company Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Further Reading
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
